ReviewRSC advances2018

Latest perspectives of orally bioavailable 2,4-diarylaminopyrimidine analogues (DAAPalogues) as anaplastic lymphoma kinase inhibitors: discovery and clinical developments.

Muhammad Latif et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.